Medindia
Medindia LOGIN REGISTER
Advertisement

Clarient Named to Deloitte's 2007 Orange County Technology Fast 50 for Third Consecutive Year

Tuesday, November 13, 2007 General News
Advertisement
ALISO VIEJO, Calif., Nov. 13 Clarient, Inc.(Nasdaq: CLRT), a premier technology and services resource for pathologists,oncologists and the pharmaceutical industry, today announced that it wasranked #19 on Deloitte's 2007 Orange County Technology Fast 50. In addition,Clarient was also named to Deloitte's 2007 Technology Fast 500 national list.
Advertisement

The 2007 Orange County Technology Fast 50 is a ranking of the 50 fastestgrowing technology, media, telecommunications and life sciences companies inOrange County, CA, based on percentage of revenue growth from 2002-2006.Deloitte's 2007 Technology Fast 500 List recognizes companies from the sameindustries across the entire nation. As reported by Deloitte, Clarientexperienced a revenue growth of 263 percent from 2002-2006, which resulted inthe notable rankings on both of Deloitte's prestigious lists.
Advertisement

Clarient's CEO Ronnie Andrews credits Clarient's strong revenue growthover the past few years to the excellent progress the Company continues tomake in the execution of its new business model and the tireless work of theentire Clarient team. "It is an honor to be recognized for the outstandingrevenue growth the company has achieved over the past few years. Our currenttrajectory is a testimony to the dedication of our employees and the executionof a sound business strategy. We believe we are well positioned to continue togrow in the coming years as we help physicians and pharmaceutical companiesfind better and more accurate ways of diagnosing and treating cancer and as weventure into new areas of recognizing and diagnosing the disease," Andrewssaid.

"Sustaining high revenue growth over five years is an exceptionalaccomplishment," said Phil Asmundson, vice chairman, U.S. Technology, Mediaand Telecommunications, Deloitte & Touche USA LLP. "We are proud to honorClarient with a ranking on the Deloitte Technology Fast 500 list."

To qualify for the Technology Fast 50, companies must have had operatingrevenues of at least $50,000 in 2002 and $5,000,000 in 2006, be headquarteredin North America, and be a company that owns proprietary technology orproprietary intellectual property that contributes to a significant portion ofthe company's operating revenues; or devotes a significant proportion ofrevenues to the research and development of technology. Using other companies'technology or intellectual property in a unique way does not qualify.Companies from the 16 regional Technology Fast 50 programs in the UnitedStates and Canada are automatically entered in Deloitte's Technology Fast 500program, which ranks North America's top 500 fastest growing technology,media, telecommunications and life sciences companies. For more information onDeloitte's Technology Fast 50 or Technology Fast 500 programs, visithttp://www.fast500.com.

About Clarient

Clarient combines innovative technologies with world class expertise toassess and characterize cancer. Clarient's mission is to provide the services,resources and critical information to improve the quality and reduce the costof patient care as well as accelerating the drug development process. TheCompany's principal customers include pathologists, oncologists, hospitals andbiopharmaceutical companies.

The rise of individualized medicine as the new direction in oncology hascreated the need for a centralized resource providing leading diagnostictechnologies such as flow cytometry and molecular testing. Clarient is thatresource, having created a state-of-the-art commercial cancer laboratoryproviding the most advanced oncology testing and drug development servicesavailable both onsite and over the web. Clarient is a Safeguard Scientifics,Inc. partner company. For more information, visit http://www.clarientinc.com.

About Safeguard

Safeguard Scientifics, Inc. (NYSE: SFE), a holding company, builds valuein growth-stage technology and life sci
Sponsored Post and Backlink Submission


Latest Press Release on General News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close